Autonomic Technologies Appoints Shashidhar Kori, M.D. As New Chief Medical Officer

Redwood City, California (ots) - Autonomic Technologies, Inc.
(ATI) announces the appointment of Dr. Shashidhar Kori, M.D. to the
position of Chief Medical Officer.

Dr. Kori has more than 30 years experience in the field of
neurosciences. Most recently, Dr. Kori was Vice President of Clinical
Development and Medical Affairs at Allergan and MAP Pharmaceuticals.
Previously he was Senior Director of Clinical Development and Senior
Medical Advisor on the Pain/Migraine Team at GlaxoSmithKline. In
these leadership roles, Dr. Kori led the design and execution of
numerous clinical studies to support product development and
commercialization, built and oversaw an active publication strategy,
created a new medical affairs department, served as liaison to the
external scientific and medical community, and had significant
involvement in new product development and discussions with global
regulatory authorities.

In his new role, Dr. Kori is responsible for clinical research,
clinical outcomes, and regulatory submissions. He will oversee
development and execution of all clinical research, including
clinical trials of the ATI Neurostimulation System for cluster
headache and migraine in Europe and the United States. He will also
lead interactions with regulatory authorities.

"Dr. Kori brings a wealth of experience to ATI from many years of
work at leading pharmaceutical companies in the headache space and
also as a physician," said Ben Pless, President and Chief Executive
Officer of ATI. "Shashi is widely recognized and well respected in
the field of neurology and neuroscience, and headache in particular.
We are pleased and fortunate to have such a capable and accomplished
leader join ATI at this important point in our company's growth."

In addition to his industry experience, Dr. Kori has a
distinguished academic career. He founded, built, and ran four large
pain programs, including the Pain and Palliative Care Program at Duke
University where he was the Founding Director. He founded and
managed large clinical and residency programs, and he held
leadership, teaching, and administrative posts at Duke University,
the University of South Florida College of Medicine, and Case Western
Reserve University. Dr. Kori has held positions in professional
organizations including the American Academy of Neurology, Southern
Pain Society, American Society for Neuroimaging, and the South
Eastern Academic Pain Consortium. He has authored more than 90
publications, served on editorial boards of medical journals, and has
given more than 150 U.S. and international invited lectures on pain
and headache management.

Dr. Kori received his medical degree from Kasturba Medical College
in Mangalore, India. He completed residencies in Internal Medicine at
the VA Medical Center in Brooklyn, NY, and Neurology at St. Vincent's
Hospital and Medical Center in New York, NY. He served fellowships in
Neuro-oncology, Neuroimmunology and Immunobiology, and Cancer Pain at
Memorial Sloan-Kettering Cancer Center, NY.

About Autonomic Technologies

Autonomic Technologies, Inc. (ATI) is a medical device company
focused on the development and commercialization of innovative
therapies for the treatment of severe headache. The company's initial
product, the ATI Neurostimulation System, is CE marked in Europe for
the treatment of cluster headache and is currently being investigated
in a multi-center, randomized study for the treatment of high
frequency, high disability migraine.

The ATI Neurostimulation System was voted #2 among the Cleveland
Clinic's top 10 medical innovations for 2013 and was chosen to
receive a 2013 Best of What's New Award from Popular Science in the
Health category. ATI was named one of FierceMedicalDevices' 2012
Fierce 15 most promising privately held medical device and
diagnostics companies in the world.

ATI is headquartered in the San Francisco Bay Area and is backed
by blue chip investors Kleiner Perkins Caufield and Byers, InterWest
Partners, Versant Ventures, Novartis Ventures, Aberdare Ventures, and
the Cleveland Clinic. For more information, visit www.ati-spg.com.

Contact:
Brit Gould
Autonomic Technologies, Inc.
+1 650 395 4230
bgould@ati-spg.com